Lotus Pharms Inc (LTUS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2022 | 09-2022 | 06-2022 | 03-2022 | 09-2011 | |
| Sales | 0 | 0 | 0 | 0 | 19,045 |
| Cost of Goods | N/A | N/A | N/A | N/A | 15,730 |
| Gross Profit | N/A | N/A | N/A | N/A | 3,310 |
| Operating Expenses | 0 | 0 | 0 | 0 | 2,770 |
| Operating Income | N/A | N/A | N/A | N/A | 1,275 |
| Interest Expense | 0 | 0 | 0 | 0 | 60 |
| Other Income | 0 | 0 | 0 | 0 | 35 |
| Pre-tax Income | 0 | 0 | 0 | 0 | 1,250 |
| Net Income Continuous | -9 | -1 | -5 | -9 | 1,253 |
| Net Income | $-9 | $-1 | $-5 | $-9 | $1,253 |
| EPS Basic Total Ops | 0.00 | 0.00 | 0.00 | 0.00 | 0.05 |
| EPS Basic Continuous Ops | 0.00 | 0.00 | 0.00 | 0.00 | 0.05 |
| EPS Diluted Total Ops | 0.00 | 0.00 | 0.00 | 0.00 | 0.04 |
| EPS Diluted Continuous Ops | 0.00 | 0.00 | 0.00 | 0.00 | 0.04 |
| EBITDA(a) | $N/A | $N/A | $N/A | $N/A | $1,685 |